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Angiogenesis or neovascularization is by definition formation of
new capillaries from pre-existing blood vessels. The process of
neovascularization in tumours is regulated by the activity of
tumour cells, stromal cells and inflammatory cells (Folkman,
1995; Fox, 1997). There is evidence from in vivo and in vitro
studies that tumour growth is dependent on neovascularization.
This applies to both benign and malignant tumours and becomes
critical after the tumour has grown beyond about 2 mm3 (Folkman,
1990). Malignant and premalignant transitional epithelium, as well
as cystitis cystica, have been shown to stimulate capillary prolifer-
ation on rabbit iris. In contrast, normal urothelium rarely had this
effect (Chodak et al, 1980).
Microvessel density (MVD), as quantified in immunohisto-
chemistry (IHC)-stained tissue sections, has proven to add prog-
nostic information in a variety of tumours (Weidner, 1995a,
1995b; Vermeulen et al, 1996; Fox, 1997), including bladder carci-
noma (Dickinson et al, 1994; Bochner et al, 1995; Jaeger et al,
1995; Hawke et al, 1996; Philp et al, 1996). However, contradic-
tory results are also reported (Weidner, 1995a, 1995b; Vermeulen
et al, 1996; Fox, 1997; Dinney et al, 1998). Although the counting
technique described by Weidner et al (1992) is sometimes referred
to as the ‘golden standard’, there is no consensus on how to
perform MVD quantifications. Several approaches have been
tried, which might, partly, explain the diverging results. Five main
issues have to be resolved in a quantification strategy:
1. The choice of antibody and staining protocol: several anti-
bodies have been tried, including factor VIII-related antigen,
CD31, CD34, vimentin, Ulex europaeus agglutinin I, collagen
IV, cathepsin B and histological stainings, such as haema-
toxylin-eosin and Masson’s trichrome. Studies performed to
evaluate which antibody is best suited for use in microvessel
quantifications have resulted in contradictory conclusions.
Besides the choice of antibody, there are also differences
between the staining protocols used, such as pretreatment
methods and chromogens. Regarding quantification strategies,
several approaches have been taken.
2. Definition of MVD: number of vessels, stained endothelial cell
area, total vessel area including lumen or perimeter.
3. Choice of area for MVD quantification: the entire tumour area,
hot spot, random, in areas of tumour invasion or in areas
representative of the overall tumour grade.
4. Total magnification: 340, 350, 3100, 3160, 3200, 3400
and 3500 (The number of microscopic fields and corre-
sponding size of the tumour area analysed vary greatly).
5. Quantification techniques: manual counting in the microscope
and manual counting in the microscope using an ocular
raster/grid, using Chalkley point eyepiece graticule, using a
projection microscope with a grid square on the table,
stereological quantification, image analysis equipment or by
subjective grading of the vessel density. These issues have
recently been reviewed by Vermeulen et al (1996) and others
(Barbareschi et al, 1995a; Weidner, 1995a, 1995b; Fox, 1997)
In the present study, a new, automatic quantification method
was used which automatically classifies an image into vessels and
background, without observer interactivity. The technique has
been recently described (Ranefall et al, 1999), proven stable
regarding variations in light and focus settings, and showed a high
concordance with manual counting of microvessels. For compar-
ison, a semi-automatic quantification method was also used. This
Automatic quantification of microvessel density in
urinary bladder carcinoma
K Wester1, P Ranefall2, E Bengtsson2, C Busch4 and P-U Malmström3
Departments of 1Genetics & Pathology, 2Centre for Image Analysis, 3Urology, Uppsala University, 75185 Uppsala, Sweden; 4Department of Pathology,
University Hospital, 9038 Tromsö, Norway
Summary Seventy-three TUR-T biopsies from bladder carcinoma were evaluated regarding microvessel density, defined as microvessel
number (nMVD) and cross-section endothelial cell area (aMVD). A semi-automatic and a newly developed, automatic image analysis
technique were applied in immunostainings, performed according to an optimized staining protocol. In 12 cases a comparison of biopsy
material and the corresponding cystectomy specimen were tested, showing a good correlation in 11 of 12 cases (92%). The techniques
proved reproducible for both nMVD and aMVD quantifications related to total tumour area. However, the automatic method was dependent on
high immunostaining quality. Simultaneous, semi-automatic quantification of microvessels, stroma and epithelial fraction resulted in a
decreased reproducibility. Quantification in ten images, selected in a descending order of MVD by subjective visual judgement, showed a poor
observer capacity to estimate and rank MVD. Based on our results we propose quantification of MVD related to one tissue compartment.
When staining quality is of high standard, automatic quantification is applicable, which facilitates quantification of multiple areas and thus,
should minimize selection variability.
Keywords: microvessel density; angiogenesis; urinary bladder; carcinoma; image analysis; automatic quantification
1363
British Journal of Cancer (1999) 81(8), 1363–1370
© 1999 Cancer Research Campaign
Article no. bjoc.1999.0853
Received 11 December 1998
Revised 10 March 1999
Accepted 20 April 1999
Correspondence to: K Wester
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observer, has also been described previously (Ranefall et al, 1997),
although not tested for microvessel quantification.
The aims of the present study were:
1. to develop an optimized IHC staining protocol suitable for
automatic quantification of microvessels
2. to compare MVD in cystectomy specimens and preceding
biopsies to assess the representativity of biopsy material
3. to evaluate both semi-automatic and automatic quantifications
of MVD with respect to intra-observer reproducibility
4. to evaluate the observer capability in discriminating different
MVD contents in neighbouring images.
MATERIALS AND METHODS
Patients
Two separate materials were analysed:
1. Twelve cases of bladder carcinoma, where both biopsy
(transurethral resection material) and the corresponding
cystectomy specimens were available, were obtained from the
Department of Pathology, University Hospital Uppsala and
used to test sampling representativity. All cases were
cystectomized without preoperative treatment.
2. Biopsy specimens from 73 patients with invasive bladder
carcinoma, stage T1–T4a (Malmstrom et al, 1996) were
collected. The patients were randomized, regarding preopera-
tive treatment, into a multicentre study (Nordic Cystectomy
Study I) and were all subsequently cystectomized. The patients
were recruited from ten hospitals in Sweden and the material
was formalin-fixed and paraffin-embedded, according to
standard procedures, at the respective local pathology
department. The study was approved by ethical committee.
Immunohistochemistry
Parallel sets of slides were IHC stained for endothelial cells (single
IHC) and for epithelial cells, as well as endothelial cells in the
same section (multiple IHC) (Figure 1).
Single IHC
Paraffin sections were cut at 4-mm thickness and placed onto
Super frost/plus® slides (Mentzel, Germany). Two mouse mono-
clonal antibodies, CD31 (clone JC70, Dako, Glostrup, Denmark)
and CD34 (clone QBEND 10, Oxoid, Basingstoke, England) were
used as a mixture, diluted 1:80 and 1:100 respectively and incu-
bated for 1 h. Prior to IHC, heat mediated antigen retrieval (AR)
was performed by boiling the slides in 0.01 M citrate buffer, pH
6.0, for 16 min at 750 W (Malmstrom et al, 1992) in a microwave
oven (Whirlpool VIP34, Sweden). Both blocking for endogenous
peroxidase in 0.3% hydrogen peroxide and preincubation in 10%
normal rabbit serum (Dako), were diluted in phosphate-buffered
saline (PBS) and incubated for 20 min. As link antibody, a
biotinylated rabbit anti-mouse (Dako) was applied, followed by a
peroxidase-labelled streptavidin–biotin complex (Dako), both
diluted 1:200 and incubated for 30 min. The slides were developed
in nickel-sulphate-enhanced DAB (Merck, Darmstadt, Germany;
Sigma, St Louis, MO, USA respectively) for 6 min (Green et al,
1989) and counterstained in lightgreen (Merck). Finally, the slides
were dehydrated through graded alcohols to xylene and mounted
in organic mounting medium. Unless otherwise stated, reagents
were diluted in 0.5% BSA-C (Aurion, Wageningen, The
Netherlands) in PBS and incubations were performed at room
temperature. Washings, for 3 ´ 10 min, between incubation
steps were done in 0.05 M Tris, pH 7.6, containing 0.3 M sodium
chloride and 0.1% Tween-20®.
Double IHC
The labelling of vessels was performed as above, except for the
AR treatment, where 1 mM EDTA (Morgan et al, 1994), pH 8.0,
was used instead of citrate buffer. After developing the first anti-
body (CD31/CD34) the slides were rinsed in tap water for 10 min
before incubation in 1% normal mouse serum (Dako) in PBS for
20 min. To visualize the epithelial structures, an anti-cytokeratin
antibody (clone AE1/AE3, Boehringer Mannheim, Mannheim,
Germany) was applied for 16 h at 4°C. The link antibody and the
streptavidin complex were diluted and incubated as above, except
that alkaline phosphatase was used as labelling enzyme. Slides
were developed in Vector red® (Vector, Burlingame, CA, USA) for
25 min, rinsed, counterstained in light green and mounted as
above.
1364 K Wester et al
British Journal of Cancer (1999) 81(8), 1363–1370 © 1999 Cancer Research Campaign
B
A
Figure 1. Microvessels highlighted by single IHC protocol (A) and by
simultaneous IHC staining of epithelial cells, multiple IHC protocol (B). Fat
arrows indicate microvessels and thin arrows tumour cell nests. Scale bars
50 µm.Image selection
In all 73 cases an area of 3–4 mm2 was outlined. The criterion used
for selecting these areas was the area subjectively judged as
containing the highest number of microvessels at the deepest level
of the bladder wall engaged by tumour, i.e. the tumour invasion
front (Figure 2). The selection was done by three observers (KW,
CB and PUM) by parallel examination of both Weigert–van
Gieson and microvessel-stained slides. The selection process was
performed before the quantifications started and without knowl-
edge of patient outcome. Semi-automatic quantifications were also
performed once without the requirement of tumour front localiza-
tion, but in invasive tumour. Quantifications were always
performed in 2 microscopic fields, except for one occasion where
10 microscopic fields were quantified, subjectively ranged in a
descending order regarding MVD. The size of the recorded images
corresponded to 0.22 mm2 per image.
Image acquisition
The 756 ´ 572 pixel colour images with 3 ´ 256 grey levels were
grabbed by a Sony DXC-151 colour video camera attached to a
standard Olympus BH-10 microscope, using 20´ objective. This
gave a final magnification of ´50 and a pixel size of about
0.8 mm for a wavelength of 550 nm. For all images, Köhler illumi-
nation was maintained and the aperture iris diaphragm ring was
fixed to 0.5.
Classification of video images and definition of
variables
The semi-automatic counting of vessel number was an algorithm
allowing the operator to label each structure, subjectively judged
as a microvessel, in an image and the result was subsequently
presented as the total number of labelled objects per image. Any
stained isolated endothelial cell or cohesive endothelial cell cluster
was considered to represent a single countable microvessel. Vessel
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Table 1 Description of antibodies against endothelial cells and cytokeratins evaluated in the study
Antibody/clone Optimal Company
dilution
Factor VIII/F8/86 1/50 DAKO, Glostrup, Denmark
CD31/JC70 1/40 DAKO, Glostrup, Denmark
CD34/QBEND10 1/50 Oxoid/Unipath Ltd, Basingstoke, UK
FVIII+CD31+CD34 (mixture) 1/100,1/80 &
1/100
CD31+CD34 (mixture) 1/80 & 1/100
Cytokeratin 10, 17 & 18/MNF116 1/200 DAKO, Glostrup, Denmark
Cytokeratin 8 1/100 AB ImmunoDevelopLab,
Sollentuna, Sweden
Cytokeratin 1–8, 10, 14–16 & 19/AE1/AE3 1/1000 Boehringer & Mannheim,
Mannheim, Germany
Cytokeratin 8 & 18/CAM 1/50 Beckton & Dickinson,
Mountain View, CA, USA
Cytokeratin 18 1/100 Sigma, St Louis, MO, USA
Cytokeratin 19 1/100 DAKO, Glostrup, Denmark
Cytokeratin 17 1/20 DAKO, Glostrup, Denmark
Table 2 Pretreatments tested in the study
Pretreatment Concentration Temperature Duration
Trypsinization 0.1% Room temperature 30 min
Protease type VIII 0.01% Room temperature 10 min
MW-citrate buffera 0.01 M Boiling 2 ´ 7 min
MW-EDTAa 0.001 M Boling 2 ´ 7 min
aMicrowave irradiation at 750 W.
BL
SU
IT
SM
PF
Figure 2. Schematic drawing of a tumour infiltrating bladder wall. Three
tumour front windows typical for various stages of a tumour are shown.
BL=bladder lumen, SU=superficial urothelium, IT=invasive tumour,
SM=smooth  muscle cell bundles and PF=perivesical fat cells.lumen or red blood cells were not necessary for a structure to be
defined as a microvessel. All muscular arteries were excluded.
The semi-automatic vessel area quantifications were based on
manually selected reference points, representing the respective
colour subclass in an image. Microvessel area, aMVD, was
defined as stained endothelial cell surface area, excluding vessel
lumen.
The automatic quantification was performed without influence
from the operator. No interactive steps were involved besides the
selection of respective image. In contrast to the semi-automatic
method, the area quantification here included information
describing both stained endothelial cell area and total vessel area.
From here on, stained endothelial cell area is refered to as aMVD.
The software was developed at the Centre for Image Analysis,
Uppsala University, Sweden and is presented in detail elsewhere
(Ranefall et al, 1997, 1998).
RESULTS
Material 1
IHC protocol evaluation
Four different antibodies to endothelial cells; and seven to cytok-
eratin were tested. Staining of endothelial cells were also tested
using cocktails, composed of two or three antibodies each, in
varying combinations and concentrations. Different pretreatment
protocols, chromogens and counterstains were also tested. Details
are shown in Tables 1–3. All stainings were evaluated by two
observers, regarding specificity, sensitivity, intensity, resolution
and contrast in the respective staining alternative. One single IHC
protocol (1 ´ IHC) was chosen because of its excellent outlining of
vessels, with a sharp contrast towards the surrounding tissue. A
mixture of CD31 and CD34 was judged as the best alternative for
visualizing the vessels. The double IHC protocol (2 ´ IHC) chosen
showed an almost equally high contrast and was also the superior
alternative for the visualization of the epithelial compartment. The
latter was mainly an effect of the antigen retrieval in EDTA-buffer
which further enhanced the cytokeratin immunostaining. The
vessel staining (CD31/CD34 mixture) was only marginally
effected by the exchange of citrate-buffer for EDTA. The two
protocols are described in detail in Materials and Methods and the
staining outcome illustrated in Figure 1.
Area selection in biopsies compared to cystectomy
specimens
In this study it is stated that MVD is quantified in microvessel ‘hot
spots’ in the tumour front (Figure 2). The question is, however: is
it possible, in fragmented biopsy specimens, to select a well-
defined area that corresponds to the ‘reality’ in cystectomy speci-
mens? Therefore, nMVD and aMVD were quantified in parallel
biopsy and cystectomy specimens. As visualized in Figure 3A an
excellent agreement for nMVD was found in 11 of 12 cases (92%),
whereas aMVD showed a good concordance in eight of 12 cases
(67%) (Figure 3B).
Material 2
Evaluation of automatic and semi-automatic quantification
Semi-automatic quantification of nMVD was highly reproducible
(r = 0.88) when related to total tumour area and applied on
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Table 3 Chromogens tested in the study
Chromogen Company Colour
DAB Sigma, St Louis, MO, USA Brown-red
Nickel-enhanced DAB Sigma, St Louis, MO, USA Black
AEC Sigma, St Louis, MO, USA Red-brown
VIP® Vector, Burlingame CA, USA Purple
Fast red® Vector, Burlingame CA, USA Red
Fast blue® Vector, Burlingame CA, USA Blue
SG® Vector, Burlingame CA, USA Grey-black
New fuchsin® DAKO, Glostrup, Denmark Red
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Figure 3. (A) Comparison of nMVD per total tumour area in parallel biopsy
and cystectomy specimens using semi-automatic quantification.
(B) Comparison of aMVD per total tumour area in parallel TUR and
cystectomy specimens using semi-automatic quantification. 1 ´ IHC stainings. The corresponding number for aMVD was 0.72.
When these quantifications were performed on 2 ´ IHC stainings,
a decreased reproducibility was observed for aMVD (r = 0.56)
whereas nMVD reproducibility was only marginally affected
(r = 0.85). In this analysis, new images were recorded for each
quantification round. If exactly the same images were quantified
on two occasions, the reproducibility was increased for nMVD and
aMVD (r = 0.97 and 0.88).
Simultaneous quantification of three compartments, vessels,
epithelium/tumour and stroma, outlined by the double IHC-
protocol and expressing MVD related to stromal fraction, was less
reproducible, r = 0.51 for nMVD and 0.43 for aMVD.
The automatic quantifications of nMVD and aMVD, applied to
single IHC stainings, showed a lower reproducibility compared to
the semi-automatic quantification, r = 0.53 and 0.65 respectively.
However, when 19 cases judged as of poor IHC staining quality
were excluded, the corresponding figures were 0.73 and 0.87
(Figure 4 A, B). The criteria for exclusion were based on a subjec-
tive judgement of the same staining qualities as described in the
‘IHC protocol evaluation’ section. This was performed by one
Microvessel density in urinary bladder carcinoma 1367
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Figure 4. (A) Automatic quantification of nMVD per total tumour area performed at two occasions, illustrating the influence of poor IHC staining quality on
reproducibility. (B) Automatic quantification of aMVD per total tumour area performed at two occasions, illustrating the influence of poor IHC staining quality on
reproducibility.
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Figure 5. (A) Association between semi-automatic and automatic quantification of nMVD, per total tumour area, including all 73 cases. (B) Association between
semi-automatic and automatic quantification of aMVD, per total tumour area, including all 73 cases.observer on two occasions resulting in a concordance in 71 of
73 cases.
There was a good agreement between semi-automatic and auto-
matic quantifications for both nMVD and aMVD respectively,
r = 0.72 and 0.75 (Figure 5 A, B). If the 19 cases of poor IHC
staining quality were excluded, the correlation improved (r = 0.80
for nMVD and 0.92 for aMVD).
It was not possible to perform three-compartment quantification
automatically.
Assessment of the intra-observer reliability regarding
selection of the highest MVD areas
Based on the subjective impression of MVD, ten images from each
case were selected, ranged in a descending order (1 to 10).
Subsequently, the subjective ranking of the images were compared
to the results from the corresponding semi-automatic quantifica-
tion. Regarding nMVD in 20 of 73 cases (27%), the subjective
impression was in agreement with the semi-automatic quantifica-
tion. The corresponding fraction for aMVD were 16 of 73 (22%).
In the discrepant cases, one or both of the images with the highest
MVD, as quantified semi-automatically, was found in images
ranked from 3 to 10 by subjective impression. The correlation
between results from quantification of 2 images (subjectively
ranked as 1 and 2) and the total 10 was good, r = 0.67 and 0.77 for
nMVD and aMVD respectively.
Quantifications in hotspot areas, chosen without further specifi-
cation within invasive tumour, was performed once. The results
were poorly correlated to, and generally higher than, quantifica-
tions performed in tumour front areas (results not shown). Hotspot
quantifications were performed by semi-automatic techniques and
no attempts were made to evaluate the reproducibility.
DISCUSSION
We have previously applied computer-based image analysis tech-
nique for malignancy grading of urinary bladder carcinoma with
promising results regarding reproducibility (Jarkrans et al, 1995;
Choi et al, 1997). In this study, we used a similar methodological
approach to assess MVD.
The validity of quantitative results from IHC-stainings are
sometimes questioned (Wold et al, 1989; Wagner, 1993; Lambkin
et al, 1994). Recently, several investigators have compared sensi-
tivity and specificity for different antibodies against endothelial
cells (Hollingsworth et al, 1995; Arakawa et al, 1997; Lee et al,
1997; Martin et al, 1997; Duarte et al, 1998), but additional factors
such as pretreatment, choice of chromogen and counterstaining are
seldom evaluated. Based on an extensive screening of available
antibodies, pretreatments and chromogens, optimized IHC-
staining protocols for visualization of the histological compart-
ments of interest were developed. Despite our efforts, using the
automatic quantification technique, 19 cases had to be excluded in
this study. Using CD31 or CD34 as single antibody, instead of a
mixture, did not alter the staining result. It is therefore reasonable
to assume that fixation and/or histoprocessing is responsible for
the poor immunostaining results. Of the excluded cases, 13
originated from three of the ten hospitals included in the study.
The exclusion rate for specimens from these three hospitals were
42, 60 and 72% respectively. This illustrates clearly one of the
major problems in standardization of IHC. The rate of poor quality
stainings probably increased because of the fact that the IHC-
staining protocols were developed and optimized on material from
one of the contributing hospitals and subsequently applied on
material from nine other hospitals. Potential variations in fixation
time, histoprocessing regimens and material storing conditions
between laboratories are known to effect the IHC-staining quality
(Leong and Gilham, 1989; Fisher et al, 1994; McDermott et al,
1997). The necessity of an initial subjective judgment of the
staining quality is a limiting factor in the development of an
objective automatic quantification method.
We suggest that the prognostic implicit of tumour angiogenesis
relates to the amount and mode of growth of the tumours.
Therefore, to express MVD related to tumour stroma area or
epithelial fraction of the tumour might add important prognostic
information. To our knowledge no such attempts have been previ-
ously made. In this study an IHC-staining protocol was developed
for the staining of both the microvessels alone and the tumour cells
alone. These three-compartmental quantifications performed were
associated with a decreased reproducibility. However, these stain-
ings proved helpful in the screening for appropriate areas, here
tumour front, for MVD quantification. The double IHC and single
IHC stainings were equally suited for semi-automatic
quantifications of nMVD related to total tumour area, whereas
semi-automatic aMVD quantifications were less suited, regarding
reproducibility, when applied to multiple IHC stainings.
Studies of MVD in urinary bladder carcinoma have investigated
biopsy (Dickinson et al, 1994; Philp et al, 1996; Nakanishi et al,
1997) and cystectomy specimens (Bochner et al, 1995; Jaeger
et al, 1995; Grossfeld et al, 1997). The latter should be more suitable
as the relation between tumour and vasculature is more easily
assessed, presumably in a more representative and reproducible
way. This is further stressed by Bochner et al (1995) who state that
most bladder tumours exhibit a large degree of heterogeneity with
respect to microvessel density. However, the preceding transurethral
resection biopsy is the basis for treatment decision and prognostica-
tion. Also only a minority of newly diagnosed cases are operated
with cystectomy. Therefore, for prognostication in clinical practice
any marker has to be evaluated in the biopsy specimen.
Comparing biopsy material and corresponding cystectomy
specimen, a major discrepancy in MVD was detected in one of
12 cases. This case exhibited a low MVD in the cystectomy
specimen (Figure 3 A, B). An explanation may be that the most
vascularized tumour fraction was removed at biopsy. There are
discrepancies between the cystectomy specimens and the frag-
mented biopsy specimens regarding evaluation of MVD.
Cystectomy specimens provide a better representation of the
tumour growth pattern. ‘Keyhole’ view in biopsy specimens illus-
trates the importance and problems of representativity. More
extensive MVD quantification in biopsies might also be a way to
minimize the effects of heterogeneity.
Different quantification strategies have been reported. In most
studies different manual counting techniques have been proposed
(Weidner et al, 1991; Dickinson et al, 1994; Jaeger et al, 1995) and
sometimes also compared with semi-automatic, image-analysis-
aided quantification of stained endothelial cell pixel area
(Barbareschi et al, 1995b; Fox et al, 1995; Kohlberger et al, 1996).
The reproducibility has been reported as moderate to high, at both
intra- and inter-observer level (Bochner et al, 1995; de Jong et al,
1995; Penfold et al, 1996; Philp et al, 1996). All methods
described hitherto are influenced by subjective decisions made by
the observer. To avoid these potential sources of intra- and inter-
observer variability, an automatic method was developed and
evaluated in comparison to semi-automatic quantification
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quantification interactivity. By minimizing the area selection
variability, this could be done more explicitly. Thus, all quantifica-
tions were performed in a strictly defined histological area,
previously demarcated on respective slides. In this way the intra-
observer reproducibility was considered as an assessment of the
quantification method stability. No attempts were made to evaluate
inter-observer or area screening reproducibility.
When semi-automatic quantification of nMVD and aMVD is
performed at two occasions on identical images the reproducibility
is high. The reproducibility for the automatic quantification here
may be regarded as perfect, even if variations in light settings and
focus are considered, as we have previously shown (Ranefall et al,
1998). When quantifications were performed within an outlined
area, but with a potential variance in the choice of image, they
were slightly less reproducible for the semi-automatic method. For
the automized quantifications this was more evident. This was due
to the latter method’s vulnerability to reduced staining quality and
inability to recognize obvious artefacts. Exclusion of cases with
visible poor IHC-staining quality resulted in a reproducibility
similar to the semi-automatic quantifications.
As observed, the intra-operator variability is more pronounced
regarding estimation of area fractions than object recognition and
counting. This is also evident when automatic and semi-automatic
quantification of aMVD are compared, where elimination of the
intra-operator variability using an automized method improves the
reproducibility (Figure 5B). On the contrary, the semi-automized
method was superior in object recognition and counting, especially
when specimens of poor IHC stainings were not excluded
(Figure 5A).
The results from the semi-automatic quantifications indicate
that the subjective selection of images, even within a small
outlined area, influenced the intra-observer reproducibility. This
was also found for the interactive quantification steps, i.e.
counting and reference point selection.
In a study performed in breast carcinoma Martin et al (1997)
concluded that finding the area with the highest MVD appeared to
be the most subjective step in microvessel quantification method-
ology. This was based on results that showed an efficiency of only
20% in finding the ‘hottest spot’ in the first chosen microscopic
field out of 10 counted. In this study a similar test resulted in a
slightly higher efficiency (27 and 22% for nMVD and aMVD
respectively). Still, in most cases an increased MVD was observed
when multiple areas were used to identify the hot spot images. The
correlation between MVD from 2 images only and the true highest
2 out of 10 was high regarding nMVD, but lower for aMVD.
Considering all images were selected within a limited area, the
consequence was that quantification of an extensive tumour
fraction led to increased hot spot recognition. Even when an
apparently homogeneous fraction within a tumour is quantified,
observer subjectivity in the selection of images generates method
variability. Using the automatic quantification technique described
here, multiple areas can be rapidly evaluated. The automized
technique reduces the quantification time up to three to four times
compared to interactive measurements (data not shown) and
simultaneously provides both number and area estimates of the
microvessels.
The medical application of computerized image analysis is a
progressing field. An increased awareness of the need for objec-
tive quantification methods together with improved equipment
performance will further promote this progress. The expensive
equipment has earlier restricted the accessibility to computerized
image analysis techniques to major hospitals and laboratories.
Today, high performance systems are available for less than
£10 000, thus increasing the number of potential users.
CONCLUSIONS
Based on our results, on reproducibility, we propose the following
schedule for assessment of MVD in urinary bladder carcinoma
biopsies:
• To perform an initial subjective evaluation of the IHC staining
quality, excluding specimens of poor quality.
• To evaluate MVD related to total tumour area using a single
chromogen IHC staining protocol.
• To use an automatic quantification technique that simultane-
ously and rapidly provides information of both number and
total vessel area as well as stained endothelial cell area.
• To quantitate in a large proportion of the tumour fraction of
interest.
This method is now being tested regarding its prognostic value,
specifically considering the choice of assessment region in the
tumour. Strictly defined regions for assessment of MVD is, in
addition, crucial to an improvement of inter-observer repro-
ducibility.
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